| COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study LYW Lee, JB Cazier, V Angelis, R Arnold, V Bisht, NA Campton, ... The Lancet 395 (10241), 1919-1926, 2020 | 1277 | 2020 |
| COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study LYW Lee, JB Cazier, T Starkey, SEW Briggs, R Arnold, V Bisht, S Booth, ... The Lancet Oncology 21 (10), 1309-1316, 2020 | 669 | 2020 |
| Application of sequencing, liquid biopsies, and patient-derived xenografts for personalized medicine in melanoma MR Girotti, G Gremel, R Lee, E Galvani, D Rothwell, A Viros, AK Mandal, ... Cancer discovery 6 (3), 286-299, 2016 | 242 | 2016 |
| Circulating tumor DNA predicts survival in patients with resected high-risk stage II/III melanoma RJ Lee, G Gremel, A Marshall, KA Myers, N Fisher, JA Dunn, N Dhomen, ... Annals of Oncology 29 (2), 490-496, 2018 | 176 | 2018 |
| Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients S Valpione, G Gremel, P Mundra, P Middlehurst, E Galvani, MR Girotti, ... European Journal of Cancer 88, 1-9, 2018 | 168 | 2018 |
| Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA L Tan, S Sandhu, RJ Lee, J Li, J Callahan, S Ftouni, N Dhomen, ... Annals of Oncology 30 (5), 804-814, 2019 | 157 | 2019 |
| Myosin II reactivation and cytoskeletal remodeling as a hallmark and a vulnerability in melanoma therapy resistance JL Orgaz, E Crosas-Molist, A Sadok, A Perdrix-Rosell, O Maiques, ... Cancer Cell 37 (1), 85-103. e9, 2020 | 138 | 2020 |
| Occupational transmission of bloodborne diseases to healthcare workers in developing countries: meeting the challenges R Lee Journal of hospital infection 72 (4), 285-291, 2009 | 106 | 2009 |
| Facilitating reproductive choices: the impact of health services on the experiences of young women with breast cancer RJ Lee, A Wakefield, S Foy, SJ Howell, AM Wardley, AC Armstrong Psycho‐oncology 20 (10), 1044-1052, 2011 | 98 | 2011 |
| Assessing the communication gap between AI models and healthcare professionals: Explainability, utility and trust in AI-driven clinical decision-making O Wysocki, JK Davies, M Vigo, AC Armstrong, D Landers, R Lee, A Freitas Artificial Intelligence 316, 103839, 2023 | 83 | 2023 |
| Optimal management of immune-related toxicities associated with checkpoint inhibitors in lung cancer M Howell, R Lee, S Bowyer, A Fusi, P Lorigan Lung Cancer 88 (2), 117-123, 2015 | 75 | 2015 |
| Mortality among adults with cancer undergoing chemotherapy or immunotherapy and infected with COVID-19 C Várnai, C Palles, R Arnold, HM Curley, K Purshouse, VWT Cheng, ... JAMA network open 5 (2), e220130-e220130, 2022 | 68 | 2022 |
| Distinct subclonal tumour responses to therapy revealed by circulating cell-free DNA G Gremel, RJ Lee, MR Girotti, AK Mandal, S Valpione, G Garner, M Ayub, ... Annals of Oncology 27 (10), 1959-1965, 2016 | 66 | 2016 |
| Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism C Monteiro, L Miarka, M Perea-García, N Priego, P García-Gómez, ... Nature medicine 28 (4), 752-765, 2022 | 63 | 2022 |
| Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero U Kini, R Lee, A Jones, S Smith, S Ramsden, A Fryer, J Clayton-Smith, ... European journal of medical genetics 50 (6), 411-420, 2007 | 39 | 2007 |
| Application of sequencing, liquid biopsies, and patient-derived xenografts for personalized medicine in melanoma. Cancer Discov. 2016; 6: 286–299. doi: 10.1158/2159-8290 MR Girotti, G Gremel, R Lee, E Galvani, D Rothwell, A Viros, AK Mandal, ... CD-15-1336.[Abstract][CrossRef][Google Scholar], 0 | 33 | |
| Dabrafenib and its use in the treatment of metastatic melanoma S Bowyer, R Lee, A Fusi, P Lorigan Melanoma Management 2 (3), 199-208, 2015 | 32 | 2015 |
| Circulating tumour DNA in melanoma—clinic ready? A Tivey, F Britton, JA Scott, D Rothwell, P Lorigan, R Lee Current Oncology Reports 24 (3), 363-373, 2022 | 30 | 2022 |
| Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort T Bhogal, UT Khan, R Lee, A Stockdale, C Hesford, V Potti-Dhananjaya, ... Leukemia & lymphoma 62 (7), 1682-1691, 2021 | 28 | 2021 |
| The paradox-breaking panRAF plus SRC family kinase inhibitor, CCT3833, is effective in mutant KRAS-driven cancers G Saturno, F Lopes, I Niculescu-Duvaz, D Niculescu-Duvaz, A Zambon, ... Annals of Oncology 32 (2), 269-278, 2021 | 28 | 2021 |